These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2876898)

  • 1. Renal effects of pinacidil in hypertensive patients on chronic beta-blocker therapy.
    Krusell LR; Christensen CK; Lederballe Pedersen O
    Eur J Clin Pharmacol; 1986; 30(6):641-7. PubMed ID: 2876898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of acute calcium blockade with nifedipine in hypertensive patients receiving beta-adrenoceptor-blocking drugs.
    Christensen CK; Lederballe Pedersen O; Mikkelsen E
    Clin Pharmacol Ther; 1982 Nov; 32(5):572-6. PubMed ID: 6751647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
    Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
    Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proximal renal tubular pressure-natriuresis-relation in essential hypertensives following acute vasodilatation.
    Krusell LR; Jespersen LT; Thomsen K; Pedersen OL
    Blood Press; 1993 Mar; 2(1):40-5. PubMed ID: 8193730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic blocking agents and the kidney.
    Bauer JH
    J Clin Hypertens; 1985 Sep; 1(3):199-221. PubMed ID: 2872278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-adrenoceptor blockade in patients with mild to moderate hypertension: long-term renal effects of doxazosin.
    Krusell LR; Christensen CK; Pedersen OL
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):440-4. PubMed ID: 1279290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
    Carlsen JE; Kardel T; Lund JO; McNair A; Trap-Jensen J
    Clin Pharmacol Ther; 1985 Mar; 37(3):253-9. PubMed ID: 2857601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute natriuretic effect of nifedipine in hypertensive patients and normotensive controls--a proximal tubular effect?
    Krusell LR; Christensen CK; Lederballe Pedersen O
    Eur J Clin Pharmacol; 1987; 32(2):121-6. PubMed ID: 3556192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term haemodynamic effects of pinacidil and hydralazine in arterial hypertension.
    Carlsen JE; Jensen HA; Rehling M; Lund JO; Trap-Jensen J
    Drugs; 1988; 36 Suppl 7():55-63. PubMed ID: 3076136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic effects of direct vasodilation (pinacidil), alpha-adrenergic blockade (prazosin) and angiotensin-converting enzyme inhibition (captopril) in systemic hypertension.
    Izzo JL; Licht MR; Smith RJ; Larrabee PS; Radke KJ; Kallay MC
    Am J Cardiol; 1987 Aug; 60(4):303-8. PubMed ID: 2887102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pinacidil on renal haemodynamics, tubular function and plasma levels of angiotensin II, aldosterone and atrial natriuretic peptide in healthy man.
    Nielsen CB; Pedersen EB
    Eur J Clin Pharmacol; 1993; 45(1):29-35. PubMed ID: 8405026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
    Friedel HA; Brogden RN
    Drugs; 1990 Jun; 39(6):929-67. PubMed ID: 2196168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
    Abraham PA; Halstenson CE; Matzke GR; Keane WF
    J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 14 years of antihypertensive treatment on renal function and urinary albumin excretion in primary hypertension.
    Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
    Am J Hypertens; 1996 Sep; 9(9):841-9. PubMed ID: 8879339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of guanabenz: a new antihypertensive.
    Bosanac P; Dubb J; Walker B; Goldberg M; Agus ZS
    J Clin Pharmacol; 1976; 16(11-12):631-6. PubMed ID: 993358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proximal tubular function in essential hypertensives on beta-blocker therapy with atenolol.
    Krusell LR; Jespersen LT; Christensen CK; Thomsen K; Pedersen OL
    Blood Press; 1997 May; 6(3):166-70. PubMed ID: 9181255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretic effect induced by intrarenal infusion of pinacidil in anesthetized dogs.
    Morimoto S; Matsumura Y; Sasaki Y; Takakuwa T; Kageyama M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1050-5. PubMed ID: 3656107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pinacidil: history, basic pharmacology, and therapeutic implications.
    Ahnfelt-Rønne I
    J Cardiovasc Pharmacol; 1988; 12 Suppl 2():S1-4. PubMed ID: 2466172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and coronary hemodynamic effects of pinacidil in awake normotensive and hypertensive dogs.
    Kawashima S; Liang CS
    Hypertension; 1985; 7(4):525-32. PubMed ID: 3891613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.
    Ward JW; McBurney A; Farrow PR; Sharp P
    Eur J Clin Pharmacol; 1984; 26(5):603-8. PubMed ID: 6468476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.